I will increase transparency and competition in the pharmacy benefit manager market to help lower prescription drug costs.

Ryan Mackenzie · Pennsylvania · Republican

policy impact 0.70 specificity 0.78 extraction confidence 88%

Commitment kind: outcome. Promised action: Increase transparency and competition among pharmacy benefit managers, including transparency around true prescription drug costs after rebates, discounts, and fees.. Promised outcome: Lower prescription drug costs and ensure patients and health plans get a better deal.. Deadline: unknown; not assumed expired. Press release from Mackenzie's U.S. House office about the Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 during his term as U.S. Representative for Pennsylvania's 7th District.

Occurrences

“Families and seniors in the Lehigh Valley and the Poconos deserve real transparency when it comes to what they pay for prescription drugs,” said Congressman Mackenzie. “Our bipartisan legislation will make it easier to understand the true cost after rebates, discounts, and fees are taken into account. By increasing transparency and competition among PBMs, we can help lower costs and ensure patients and health plans are getting a better deal.”

Mackenzie said his bipartisan legislation would make prescription drug costs easier to understand after rebates, discounts, and fees, and would increase transparency and competition among PBMs to help lower costs.

Mackenzie Introduces Bipartisan Bill to Increase Transparency in Prescription Drug Market | Congressman Ryan Mackenzie
primary · press_release · model gpt-5.5

Evidence

No stored evidence yet.

Assessments

No assessments yet.